Anja Schutz

Franz Josef Strauß Allee 11
Regensburg, BY 93053, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis.

Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis.

Journal: ACS pharmacology & translational science

Published: January 15, 2025

IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations.

IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations.

Journal: EMBO molecular medicine

Published: October 04, 2024

Author Correction: IFNγ binding to extracellular matrix prevents fatal systemic toxicity.

Author Correction: IFNγ binding to extracellular matrix prevents fatal systemic toxicity.

Journal: Nature immunology

Published: April 19, 2024

Arginine methylation of the p30 C/EBPα oncoprotein regulates progenitor proliferation and myeloid differentiation.

Arginine methylation of the p30 C/EBPα oncoprotein regulates progenitor proliferation and myeloid differentiation.

Journal: iScience

Published: April 10, 2024

CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment.

CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment.

Journal: EMBO molecular medicine

Published: February 22, 2024

Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles as Highly Potent and In Vivo Efficacious Tryptophan Hydroxylase Inhibitors.

Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles as Highly Potent and In Vivo Efficacious Tryptophan Hydroxylase Inhibitors.

Journal: Journal of medicinal chemistry

Published: October 31, 2023

An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor.

An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor.

Journal: eLife

Published: October 16, 2023

AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2023

A concise guide to choosing suitable gene expression systems for recombinant protein production.

A concise guide to choosing suitable gene expression systems for recombinant protein production.

Journal: STAR protocols

Published: May 18, 2023

AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

Journal: Molecular systems biology

Published: February 09, 2023

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Journal: Frontiers in immunology

Published: December 07, 2022

Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.

Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 03, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026